Literature DB >> 26845672

Immune activation and HIV: an enduring relationship.

Irini Sereti1, Marcus Altfeld.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26845672      PMCID： PMC4748385          DOI： 10.1097/COH.0000000000000244

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN： 1746-630X            Impact factor:   4.283


× No keyword cloud information.
  19 in total

Review 1.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 2.  HIV replication: a game of hide and sense.

Authors:  Daniel Sauter; Frank Kirchhoff
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

3.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

4.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

5.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.

Authors:  J V Giorgi; Z Liu; L E Hultin; W G Cumberland; K Hennessey; R Detels
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-08

6.  Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

Authors:  J F Salazar-Gonzalez; O Martinez-Maza; P Nishanian; N Aziz; L P Shen; S Grosser; J Taylor; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

Review 7.  Maternal HIV infection alters the immune balance in the mother and fetus; implications for pregnancy outcome and infant health.

Authors:  Caroline Pfeifer; Madeleine J Bunders
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 8.  Immune activation and paediatric HIV-1 disease outcome.

Authors:  Julia M Roider; Maximilian Muenchhoff; Philip J R Goulder
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 9.  Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.

Authors:  Alexander S Zevin; Lyle McKinnon; Adam Burgener; Nichole R Klatt
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069
View more
  18 in total

1.  SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.

Authors:  Patrick O'Connell; Yuliya Pepelyayeva; Maja K Blake; Sean Hyslop; Robert B Crawford; Michael D Rizzo; Cristiane Pereira-Hicks; Sarah Godbehere; Linda Dale; Peter Gulick; Norbert E Kaminski; Andrea Amalfitano; Yasser A Aldhamen
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

2.  The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.

Authors:  Luisa Mori; Katharine Jenike; Yang-Hui Jimmy Yeh; Benoît Lacombe; Chuan Li; Adam Getzler; Sonia Mediouni; Michael Cameron; Matthew Pipkin; Ya-Chi Ho; Bertha Cecilia Ramirez; Susana Valente
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

3.  Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers.

Authors:  Sunitha Kodidela; Sabina Ranjit; Namita Sinha; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

Review 4.  Cure and Long-Term Remission Strategies.

Authors:  Luisa Mori; Susana T Valente
Journal:  Methods Mol Biol       Date:  2022

5.  Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.

Authors:  Alessandra Ruggiero; Giuseppe Rubens Pascucci; Nicola Cotugno; Sara Domínguez-Rodríguez; Stefano Rinaldi; Alfredo Tagarro; Pablo Rojo; Caroline Foster; Alasdair Bamford; Anita De Rossi; Eleni Nastouli; Nigel Klein; Elena Morrocchi; Benoit Fatou; Kinga K Smolen; Al Ozonoff; Michela Di Pastena; Katherine Luzuriaga; Hanno Steen; Carlo Giaquinto; Philip Goulder; Paolo Rossi; Ofer Levy; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

Review 6.  HIV as a Cause of Immune Activation and Immunosenescence.

Authors:  T Sokoya; H C Steel; M Nieuwoudt; T M Rossouw
Journal:  Mediators Inflamm       Date:  2017-10-25       Impact factor: 4.711

Review 7.  Host genetic variation and HIV disease: from mapping to mechanism.

Authors:  Vivek Naranbhai; Mary Carrington
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

8.  Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.

Authors:  Alessandra Ruggiero; Alessandro Cozzi-Lepri; Apostolos Beloukas; Douglas Richman; Saye Khoo; Andrew Phillips; Anna Maria Geretti
Journal:  Open Forum Infect Dis       Date:  2018-02-03       Impact factor: 3.835

Review 9.  Regulatory T cells in retroviral infections.

Authors:  Kim J Hasenkrug; Claire A Chougnet; Ulf Dittmer
Journal:  PLoS Pathog       Date:  2018-02-15       Impact factor: 6.823

10.  Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure.

Authors:  Haishan Li; Tyler Lahusen; Lingzhi Xiao; Nidal Muvarak; Jana Blazkova; Tae-Wook Chun; C David Pauza
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-03       Impact factor: 6.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.